JPRN-UMIN000003933已完成2 期
Phase II trial of amrubicin and cisplatin chemotherapy for invasive thymoma - Amrubicin and cisplatin for invasive thymoma
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Other malignancy (exception: non-melanoma skin cancer, cervical carcinoma in situ, cancer without evidence more than 5 years since curative resection) pregnant, or lactating women active bacterial infection Severe, medical condition unstable cardiac disease despite of adequate management myocardial infarction within 6 months. Uncontorllable diabetes mellitus or hypertension or glaucoma. Interstitial lung diesease Active ulcer disease Continuers corticosteroids therapy. Uncontrolled Psychiatric problem which decrease treatment
研究者
相似试验
已完成
2 期
a phase II trial of amrubicin and carboplatin for patients with extensive stage small cell lung cancersmall cell lung cancerJPRN-UMIN000001115agasaki Thoracic Oncology Group35
招募中
1 期
Phase I study of Amrubicin plus CISplatin and concurrent accelerated hyperfractionated thoracic radioTherapy for limited-disease small cell lung cancerJPRN-jRCT1071200033Taniguchi Hirokazu9
未知
Unknown
Phase I/II study of Amrubicin with Cisplatin in patients with advanced Non-small cell lung cancerAdvanced Non-small cell lung cancerJPRN-jRCT1080221989Dainippon Sumitomo Pharma Co., Ltd.46
已完成
2 期
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung CancerExtensive-Stage Small Cell Lung CancerNCT01076504SCRI Development Innovations, LLC81
已完成
不适用
Phase II trial of amrubicin treatment as palliative-intended chemotherapy for previously treated malignant pleural mesotheliomamalignant pleural mesotheliomaJPRN-UMIN000010739Tokyo Metropolitan Cancer and Infection diseases Center Komagome Hospital6